KEMPHARMA LTD

Registered Number
09021132
(England and Wales)

Unaudited Dormant Financial Statements for the Year ended
30 April 2026

KEMPHARMA LTD

Company Information
for the year from 1 May 2025 to 30 April 2026


Director	ROBERTS, Olukemi Ganiat


Registered Number	09021132 (England and Wales)

KEMPHARMA LTD

Balance Sheet as at
30 April 2026

	2026 £	2025 £
Assets
Fixed Assets	1,452	1,452
Current Assets	812	804
	2,264	2,256
Capital, Reserves and Liabilities
Capital and reserves	(50,568)	(49,659)
Creditors amounts falling due within one year	47,683	38,758
Creditors amounts falling due after one year	4,702	12,710
Accruals and deferred income	447	447
	2,264	2,256

The company is a private company limited by shares and registered in England and Wales. It was dormant and has not traded during this reporting period and it was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the Director on 14 August 2026, and are signed on its behalf by:

ROBERTS, Olukemi Ganiat
Director
Registered Company No. 09021132